28 results on '"Chung-Faye, G"'
Search Results
2. AWE-08 Why are we missing colorectal cancer? A study investigating the cause of delays in diagnosis
3. P716 The use of tacrolimus in patients with ulcerative colitis resistant to standard medical therapy
4. P729 A ‘real-world’ retrospective multi-centre study comparing infliximab and adalimumab for the maintenance of remission in ulcerative colitis
5. P599 Home testing for faecal calprotectin: follow-up results from the first UK trial
6. P129 Persistent intestinal inflammation leads to surgical intervention in Crohn's patients: a nested case-control study
7. PWE-024 Early Change in Faecal Calprotectin Predicts Primary Non- Response to Anti-TNFΑ Therapy in Inflammatory Bowel Disease
8. PTU-062 Vedolizumab: Early Experience and Medium-Term Follow up Data from Two UK Tertiary IBD Centres
9. PTH-013 Endorings™ In Screening Colonoscopy: Results of A Single Centre Pilot Study
10. PTH-054 Home-Testing of Faecal Calprotectin Using the IBDoc™ System: A Comparative Pilot Study
11. PTU-074 Vedolizumab in Primary and Autoimmune Sclerosing Cholangitis Associated Inflammatory Bowel Disease Pre and Post Liver Transplantation: A Case Series
12. PTH-059 Faecal calprotectin identifies non responders to anti-tnfΑ therapy when measured after induction in inflammatory crohn’s disease
13. PTU-080 Calprotectin predicts relapse of ibd even in the presence of a ‘normal’ colonoscopy
14. PTH-058 Long-term prognosis of patients presenting with gastrointestinal symptoms and abnormal calprotectin diagnosed with non-organic disease
15. PWE-009 Evaluation of out-of-hours emergency endoscopy outcomes at a large liver and gastrointestinal centre
16. PTU-182 Specialist Care Of In-patients With Non-variceal Upper Gastrointestinal Bleeding Is Associated With A Significant Shorter Length Of Stay – A Prospective Analysis: Abstract PTU-182 Table 1
17. P403 Normalisation of faecal calprotectin is an absolute marker of mucosal healing and predicts long-term remission in ulcerative colitis (UC)
18. P482 Faecal calprotectin can be used to monitor response to therapy in anti-TNF treated patients with Crohn's disease
19. P219 Faecal calprotectin is an accurate predictor of endoscopic and histological disease activity in IBD
20. P114 The influence of obesity on clinical course and behaviour of Crohn's disease
21. OC-023 Specialist Care of in-Patients with Non-Variceal upper Gastrointestinal Bleeding is Associated with a Dramatically Shorter Length of Stay: Abstract OC-023 Table
22. The natural history of perianal disease
23. Health-economic analysis: cost-effectiveness of scheduled maintenance treatment with infliximab for Crohn’s disease - modelling outcomes in active luminal and fistulizing disease in adults
24. P278 IS SCHEDULED MAINTENANCE TREATMENT WITH INFLIXIMAB COST EFFECTIVE IN PATIENTS WITH CROHN'S DISEASE?
25. Remission and relapse of Crohn's disease following autologous haematopoietic stem cell transplantation for non-Hodgkin's lymphoma
26. Colorectal cancer screening
27. ABC of colorectal cancer: Innovative treatment for colon cancer
28. Diverticular disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.